News from the Blakely Lab
Also, see her recent publication: Nemeth DP, Liu X, Monet MC, Niu H, Maxey G, Schrier MS, Smirnova MI, McGovern SJ, Herd A, DiSabato DJ, Floyd T, Atluri RR, Nusstein AC, Oliver B, Witcher KG, Juste Ellis JS, Yip J, Crider AD, McKim DB, Gajewski-Kurdziel PA, Godbout JP, Zhang Q, Blakely RD, Sheridan JF, Quan N.J. Localization of brain neuronal IL-1R1 reveals specific neural circuitries responsive to immune signaling. Neuroinflammation. 2024 Nov 19;21(1):303. doi: 10.1186/s12974-024-03287-1.PMID: 39563437
Also, see his recent publication: Kappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant. Mayer FP, Stewart A, Varman DR, Moritz AE, Foster JD, Owens AW, Areal LB, Gowrishankar R, Velez M, Wickham K, Phelps H, Katamish R, Rabil M, Jayanthi LD, Vaughan RA, Daws LC, Blakely RD, Ramamoorthy S.Mol Psychiatry. 2025 Oct;30(10):4651-4664. doi: 10.1038/s41380-025-03055-4. PMID: 40442453
Also see her recent publication: Stewart A, Blakely RD. The Ins and Outs of Dopamine Transporter Gene Manipulation: In Vivo Models of DAT Dysfunction. Adv Neurobiol. 2025;46:235-270. doi: 10.1007/978-3-031-96364-3_10.PMID: 41051713